Neurological Disorders
-
PreveCeutical Files Patent for Novel CNS Agent Delivery System
PreveCeutical Medical Inc. has filed a patent for a novel drug delivery system targeting the central nervous system. This technology aims to overcome the blood-brain barrier, a major obstacle for treating neurological and psychiatric disorders. By enhancing drug bioavailability and targeted delivery, the system could enable more effective and safer treatments for conditions like Alzheimer’s and Parkinson’s, potentially revolutionizing therapies and opening new avenues for drug development.